Simplex Trading’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-50
| Closed | -$1K | – | 8337 |
|
|
2019
Q2 | $1K | Sell |
50
-289
| -85% | -$780 | ﹤0.01% | 6975 |
|
|
2019
Q1 | $156K | Buy |
339
+309
| +1,030% | +$1.46K | ﹤0.01% | 3877 |
|
|
2018
Q4 | $10K | Sell |
30
-26
| -46% | -$181 | ﹤0.01% | 5883 |
|
|
2018
Q3 | $56K | Sell |
56
-199
| -78% | -$1.59K | ﹤0.01% | 5063 |
|
|
2018
Q2 | $184K | Buy |
255
+159
| +166% | +$1.11K | ﹤0.01% | 3599 |
|
|
2018
Q1 | $43K | Buy |
96
+65
| +210% | +$537 | ﹤0.01% | 2591 |
|
|
2017
Q4 | $2K | Buy |
31
+18
| +138% | +$118 | ﹤0.01% | 5351 |
|
|
2017
Q3 | $8K | Sell |
13
-59
| -82% | -$609 | ﹤0.01% | 4044 |
|
|
2017
Q2 | $9K | Sell |
72
-5
| -6% | -$59 | ﹤0.01% | 4111 |
|
|
2017
Q1 | $25K | Sell |
77
-669
| -90% | -$7.13K | ﹤0.01% | 3041 |
|
|
2016
Q4 | $97K | Buy |
746
+492
| +194% | +$5.56K | 0.01% | 1563 |
|
|
2016
Q3 | $59K | Sell |
254
-109
| -30% | -$1.66K | ﹤0.01% | 1967 |
|
|
2016
Q2 | $107K | Sell |
363
-64
| -15% | -$933 | 0.01% | 1428 |
|
|
2016
Q1 | $63K | Buy |
427
+364
| +578% | +$6.91K | 0.01% | 1754 |
|
|
2015
Q4 | $59K | Sell |
63
-31
| -33% | -$859 | ﹤0.01% | 1797 |
|
|
2015
Q3 | $73K | Sell |
94
-214
| -69% | -$7.88K | 0.01% | 1678 |
|
|
2015
Q2 | $64K | Buy |
+308
| New | +$9.59K | 0.01% | 1519 |
|
Simplex Trading's INSY Position: Q1 2019 in Review
Simplex Trading sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 1,075 shares — an estimated $5.09K sold.
Simplex Trading first reported a position in INSY in Q1 2016 and held it in 11 quarters. The position peaked at $554K in Q2 2016. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.
- Simplex Trading reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
- Simplex Trading sold 1,075 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $5.09K.
- Simplex Trading first reported a position in Insys Therapeutics, Inc. in Q1 2016 and held it in 11 quarters.
- Simplex Trading's Insys Therapeutics, Inc. position peaked at $554K in Q2 2016.
- 98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.
Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.